1. Home
  2. UBX vs CLRO Comparison

UBX vs CLRO Comparison

Compare UBX & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • CLRO
  • Stock Information
  • Founded
  • UBX 2009
  • CLRO 1983
  • Country
  • UBX United States
  • CLRO United States
  • Employees
  • UBX N/A
  • CLRO N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • CLRO Radio And Television Broadcasting And Communications Equipment
  • Sector
  • UBX Health Care
  • CLRO Technology
  • Exchange
  • UBX Nasdaq
  • CLRO Nasdaq
  • Market Cap
  • UBX 13.9M
  • CLRO 12.5M
  • IPO Year
  • UBX 2018
  • CLRO N/A
  • Fundamental
  • Price
  • UBX $0.78
  • CLRO $5.71
  • Analyst Decision
  • UBX Strong Buy
  • CLRO
  • Analyst Count
  • UBX 3
  • CLRO 0
  • Target Price
  • UBX $4.67
  • CLRO N/A
  • AVG Volume (30 Days)
  • UBX 609.1K
  • CLRO 33.5K
  • Earning Date
  • UBX 08-05-2025
  • CLRO 08-14-2025
  • Dividend Yield
  • UBX N/A
  • CLRO 130.44%
  • EPS Growth
  • UBX N/A
  • CLRO N/A
  • EPS
  • UBX N/A
  • CLRO N/A
  • Revenue
  • UBX N/A
  • CLRO $10,077,000.00
  • Revenue This Year
  • UBX N/A
  • CLRO N/A
  • Revenue Next Year
  • UBX N/A
  • CLRO N/A
  • P/E Ratio
  • UBX N/A
  • CLRO N/A
  • Revenue Growth
  • UBX N/A
  • CLRO N/A
  • 52 Week Low
  • UBX $0.36
  • CLRO $4.35
  • 52 Week High
  • UBX $3.10
  • CLRO $21.00
  • Technical
  • Relative Strength Index (RSI)
  • UBX 48.12
  • CLRO 37.58
  • Support Level
  • UBX $0.67
  • CLRO $4.98
  • Resistance Level
  • UBX $0.83
  • CLRO $8.91
  • Average True Range (ATR)
  • UBX 0.09
  • CLRO 0.86
  • MACD
  • UBX 0.01
  • CLRO 0.00
  • Stochastic Oscillator
  • UBX 24.67
  • CLRO 6.62

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About CLRO ClearOne Inc. (DE)

ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.

Share on Social Networks: